Essential Partners’s Veracyte VCYT Stock Holding History

Essential Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294	Buy	5 +4	+400%	+$168	﹤0.01%	2569
2026 Q1	$32	Buy	+1	New	+$37	﹤0.01%	2805

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Essential Partners's VCYT Position: Q2 2026 in Review

Essential Partners increased its Veracyte (VCYT) stake by 400% in Q2 2026, buying an estimated $168 and bringing the position to 5 shares worth $294. The position accounts for ﹤0.01% of the portfolio, ranked #2569.

Essential Partners first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Essential Partners held 5 shares of Veracyte worth $294 as of Q2 2026.
Essential Partners bought 4 Veracyte shares in Q2 2026, an estimated $168.
Veracyte made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2569 holding.
Essential Partners first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.